194 related articles for article (PubMed ID: 8996236)
1. Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor.
Ammer H; Schulz R
J Pharmacol Exp Ther; 1997 Jan; 280(1):512-20. PubMed ID: 8996236
[TBL] [Abstract][Full Text] [Related]
2. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
3. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
5. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
6. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
7. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
8. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
9. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
[TBL] [Abstract][Full Text] [Related]
10. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.
Chaipatikul V; Loh HH; Law PY
J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655
[TBL] [Abstract][Full Text] [Related]
11. Receptor endocytosis counteracts the development of opioid tolerance.
Koch T; Widera A; Bartzsch K; Schulz S; Brandenburg LO; Wundrack N; Beyer A; Grecksch G; Höllt V
Mol Pharmacol; 2005 Jan; 67(1):280-7. PubMed ID: 15475572
[TBL] [Abstract][Full Text] [Related]
12. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
Szücs M; Boda K; Gintzler AR
J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
[TBL] [Abstract][Full Text] [Related]
13. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.
Shy M; Chakrabarti S; Gintzler AR
Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853
[TBL] [Abstract][Full Text] [Related]
14. Chronic morphine acts via a protein kinase Cgamma-G(beta)-adenylyl cyclase complex to augment phosphorylation of G(beta) and G(betagamma) stimulatory adenylyl cyclase signaling.
Chakrabarti S; Regec A; Gintzler AR
Brain Res Mol Brain Res; 2005 Jul; 138(1):94-103. PubMed ID: 15908039
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
Wagner EJ; Rønnekleiv OK; Kelly MJ
J Pharmacol Exp Ther; 1998 Jun; 285(3):1266-73. PubMed ID: 9618432
[TBL] [Abstract][Full Text] [Related]
16. Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure.
Schallmach E; Steiner D; Vogel Z
Neuropharmacology; 2006 Jun; 50(8):998-1005. PubMed ID: 16545401
[TBL] [Abstract][Full Text] [Related]
17. Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptor.
Xu H; Wang X; Zimmerman D; Boja ES; Wang J; Bilsky EJ; Rothman RB
J Pharmacol Exp Ther; 2005 Oct; 315(1):248-55. PubMed ID: 15987828
[TBL] [Abstract][Full Text] [Related]
18. Adenylyl cyclase supersensitivity in opioid-withdrawn NG108-15 hybrid cells requires Gs but is not mediated by the Gsalpha subunit.
Ammer H; Schulz R
J Pharmacol Exp Ther; 1998 Aug; 286(2):855-62. PubMed ID: 9694942
[TBL] [Abstract][Full Text] [Related]
19. Functional coupling of a mu opioid receptor to G proteins and adenylyl cyclase: modulation by chronic morphine treatment.
Chen Y; Liu J; Yu L
Addict Biol; 1996; 1(1):49-59. PubMed ID: 12893486
[TBL] [Abstract][Full Text] [Related]
20. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
Chuchuen U; Ebadi M; Govitrapong P
J Pineal Res; 2004 Nov; 37(4):223-9. PubMed ID: 15485547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
